Cited by 219Nanoparticle-Based Drug DeliveryAlzheimer's disease research and treatmentsAdvanced Drug Delivery Systems

The DOI matches its Crossref record; 351 of the 352 references it cites were found in a registry or an index.

Neurotherapeutic applications of nanoparticles in Alzheimer’s disease

Sahni, Jasjeet Kaur, Doggui, Sihem, Ali, Javed, Baboota, Sanjula, Dao, Lé, Ramassamy, Charles·2011·Journal of Controlled Release

DOI 10.1016/j.jconrel.2010.11.033

Open this paper in CoChat — free account

Abstract

A rapid increase in incidence of neurodegenerative disorders has been observed with the aging of the population. Alzheimer's disease (AD) is the most common neurodegenerative disorder among the elderly. It is characterized by memory dysfunction, loss of lexical access, spatial and temporal disorientation and impairment of judgement clinically. Unfortunately, clinical development of drugs for the symptomatic and disease-modifying treatment of AD has resulted in both promise and disappointment. Indeed, a large number of drugs with differing targets and mechanisms of action were investigated with only a few of them being clinically available. The targeted drug delivery to the central nervous system (CNS), for the diagnosis and treatment of neurodegenerative disorders such as AD, is restricted due to the limitations posed by the blood-brain barrier (BBB) as well as due to opsonization by plasma proteins in the systemic circulation and peripheral side-effects. Over the last decade, nanoparticle-mediated drug delivery represents one promising strategy to successfully increase the CNS penetration of several therapeutic moieties. Different nanocarriers are being investigated to treat and diagnose AD by delivering at a constant rate a host of therapeutics over times extending up to days, weeks or even months. This review provides a concise incursion on the current pharmacotherapies for AD besides reviewing and discussing the literature on the different drug molecules that have been successfully encapsulated in nanoparticles (NPs). Some of them have been shown to cross the BBB and have been tested either for diagnosis or treatment of AD. Finally, the route of NPs administration and the future prospects will be discussed.

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2010.11.033

Cites

351 of 351 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: α-Lipoic acid exhibits anti-amyloidogenicity for β-amyloid fibrils in vitro
Ono, K., Hirohata, M., & Yamada, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.063 · Cited by 60
Retracted
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Structure-antioxidant activity relationships of flavonoids and phenolic acids
Rice-Evans, C. A., Miller, N. J., & Paganga, G. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02227-9 · Cited by 9,085
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Dietary Intake and Bioavailability of Polyphenols
Scalbert, A., & Williamson, G. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.8.2073s · Cited by 3,658
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627

Show all 352 references

Research works printed but not linked: 7

Singh, 2008, Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms, J. Agric. Food Chem., 56, 4855, 10.1021/jf0735073 · DOI
Bieschke, 2010, EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity, Proc. Natl Acad. Sci. USA, 107, 7710, 10.1073/pnas.0910723107 · DOI
Jang, 2003, Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death, Free Radic. Biol. Med., 34, 1100, 10.1016/S0891-5849(03)00062-5 · DOI
Sharma, 2002, Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats, Life Sci., 71, 2489, 10.1016/S0024-3205(02)02083-0 · DOI
Wilson, 2010, Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine, Nanomed. Nanotechnol. Biol. Med., 6, 144, 10.1016/j.nano.2009.04.001 · DOI
Wilson, 2008, Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease, Brain Res., 1200, 159, 10.1016/j.brainres.2008.01.039 · DOI · Paper page
Reiter, 2003, Melatonin: clinical relevance, Best Pract. Res. Clin. Endocrinol. Metab., 17, 273, 10.1016/S1521-690X(03)00016-2 · DOI

Sorted by citations

Items 101–200 of 219

Interaction Dynamics in Inhibiting the Aggregation of Aβ Peptides by SWCNTs: A Combined Experimental and Coarse-Grained Molecular Dynamic Simulation Study
Lin, D., Qi, R., Li, S., He, R., Li, P., Wei, G., & Yang, X. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00101 · Cited by 33
Recent Progress of Nanomedicine in the Treatment of Central Nervous System Diseases
Feng, L., Wang, H., & Xue, X. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900159 · Cited by 33
Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier
Alves, P. A., Camargo, L. C., de Souza, G. M., Mortari, M. R., & Homem-de-Mello, M. (2025) · Pharmaceuticals · doi:10.3390/ph18020217 · Cited by 35
Nanoscale drug formulations for the treatment of Alzheimer's disease progression
Liqin, L., He, H., Du, B., & He, Y. (2025) · RSC Advances · doi:10.1039/d4ra08128e · Cited by 38
Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
Javdani, N., Rahpeyma, S. S., Ghasemi, Y., & Raheb, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s190354 · Cited by 31
Interaction of natural compounds with biomembrane models: A biophysical approach for the Alzheimer’s disease therapy
Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.019 · Cited by 32
Nanoparticles loaded with natural medicines for the treatment of Alzheimer’s disease
Liu, N., Ruan, J., Li, H., & Fu, J.-H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1112435 · Cited by 36
Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease
Unnisa, A., Greig, N. H., & Kamal, M. A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220328125206 · Cited by 28
Multifunctional nano-enabled delivery systems in Alzheimer's disease management
Qian, C., Yuan, C., Li, C., Liu, H., & Wang, X. (2020) · Biomaterials Science · doi:10.1039/d0bm00756k · Cited by 28
Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers
Ansari, M. A., Tripathi, T., Venkidasamy, B., Monziani, A., Rajakumar, G., Alomary, M. N., Alyahya, S. A., Onimus, O., D’souza, N., Barkat, M. A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03730-z · Cited by 29
Castanea sativa Mill. Bark Extract Protects U‐373 MG Cells and Rat Brain Slices Against Ischemia and Reperfusion Injury
Santulli, C., Brizi, C., Micucci, M., Ambra, D. G., Cristofaro, A. D., Bracco, F., Lucia, P. G., Ilaria, D. P., Budriesi, R., Chiarini, A., et al. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25760 · Cited by 27
A copper–amyloid-β targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease
Yang, T., Liu, Y., Zhang, C., Wang, Y., Ma, X., Wang, K., Luo, J. H., Yao, C., Wang, X., & Wang, X. (2016) · Inorganic Chemistry Frontiers · doi:10.1039/c6qi00268d · Cited by 26
Safety protocol for the gold nanoparticles administration in rats
Muller, A. P., Ferreira, G. K., da Silva, S., Nesi, R. T., Silveira, G. D. B., Mendes, C., Pinho, R. A., Paula, M. M. D. S., & Silveira, P. C. L. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.04.027 · Cited by 26
RTHLVFFARK-NH2: A potent and selective modulator on Cu2+-mediated amyloid-β protein aggregation and cytotoxicity
Meng, J., Zhang, H., Dong, X., Liu, F., & Sun, Y. P. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.01.012 · Cited by 26
Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases
Rice, O., Surian, A., & Chen, Y. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221095997 · Cited by 25
Green synthesis of nanoparticles using medicinal plants as an eco-friendly and therapeutic potential approach for neurodegenerative diseases: a comprehensive review
Izadi, R., Bahramikia, S., & Akbari, V. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1453499 · Cited by 24
Gamma radiation preparation of chitosan nanoparticles for controlled delivery of memantine
Radwan, R. R., Ghaffar, A. M. A., & Ali, H. E. (2019) · Journal of Biomaterials Applications · doi:10.1177/0885328219890071 · Cited by 23
How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer’s disease treatment?
Séguy, L., Groo, A., & Malzert‐Fréon, A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.022 · Cited by 23
Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer’s and Parkinson’s Disease
Soursou, G., Alexiou, A. T., Ashraf, G. M., Siyal, A. A., Mushtaq, G., & Kamal, M. A. (2015) · Current Drug Metabolism · doi:10.2174/138920021608151107125049 · Cited by 22
Effect of temperature on the synthesis of Centella asiatica flavonoids extract-mediated gold nanoparticles: UV-visible spectra analyses
Latif, M. S., Kormin, F. B., Mustafa, M. K., Mohamad, I. I., Khan, M. A., Abbas, S., Ghazali, M. I., Shafie, N. S., Bakar, M. F. A., Sabran, S. F., et al. (2018) · AIP conference proceedings · doi:10.1063/1.5055473 · Cited by 21
Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery
Wu, Y., Rakotoarisoa, M., Angelov, B., Deng, Y., & Angelova, A. (2022) · Nanomaterials · doi:10.3390/nano12132267 · Cited by 21
Phase inversion of medium-chain-length poly-3-hydroxyalkanoates (mcl-PHA)-incorporated nanoemulsion: effects of mcl-PHA molecular weight and amount on its mechanism
Ishak, K. A., & Annuar, M. S. M. (2016) · Colloid & Polymer Science · doi:10.1007/s00396-016-3957-9 · Cited by 21
Liposome-embedded, polymeric scaffold for extended delivery of galantamine
Mufamadi, M. S., Kumar, P., du Toit, L. C., Choonara, Y. E., Obulapuram, P. K., Modi, G., Naidoo, D., Iyuke, S. E., & Pillay, V. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.02.001 · Cited by 22
A novel dendritic mesoporous silica based sustained hydrogen sulfide donor for the alleviation of adjuvant-induced inflammation in rats
Yu, Y., Wang, Z., Yang, Q., Ding, Q., Wang, R., Li, Z., Fang, Y., Liao, J., Qi, W., Chen, K., et al. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1921075 · Cited by 20
Regenerative medicine improve neurodegenerative diseases
Ashraf, S. S., Sarmadi, V. H., Larijani, G., Gharahgheshlagh, S. N., Ramezani, S., Moghadamifar, S., Mohebbi, S. L., Milan, P. B., Haramshahi, S. M. A., Ahmadirad, N., et al. (2022) · Cell and Tissue Banking · doi:10.1007/s10561-022-10062-0 · Cited by 20
A Nanotechnological Approach to the Management of Alzheimer Disease and Type 2 Diabetes
Alam, Q., ZubairAlam, M., Karim, S., Gan, S. H., Kamal, M. A., Jiman-Fatani, A. A., Damanhouri, G., Abuzenadah, A. M., Chaudhary, A., & Haque, A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660159 · Cited by 19
The Road from Nanomedicine to Precision Medicine
Rakotoarisoa, M., & Angelova, A. (2020) · doi:10.1201/9781003027010 · Cited by 19
Neuroprotective effects of three different sizes nanochelating based nano complexes in MPP(+) induced neurotoxicity
Maghsoudi, A., Fakharzadeh, S., Hafizi, M., Abbasi, M., Kohram, F., Sardab, S., Tahzibi, A., Kalanaky, S., & Nazaran, M. H. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1069-x · Cited by 19
Therapeutic and Diagnostic Applications of Nanocomposites in the Treatment Alzheimer’s Disease Studies
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac121.940960 · Cited by 21
Mechanistic study of gold nanoparticles of Vildagliptin and Vitamin E in diabetic cognitive impairment
Pradhan, S. P., Tejaswani, P., Sa, N., Behera, A., Sahoo, R. K., & Sahu, P. K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104508 · Cited by 18
A Preliminary Pharmacodynamic Study for the Management of Alzheimer’s Disease Using Memantine-Loaded PLGA Nanoparticles
Kaur, A., Nigam, K., Tyagi, A. K., & Dang, S. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02449-9 · Cited by 18
Potential of drug-loaded Nanoparticles for Alzheimer‘s Disease: diagnosis, Prevention and Treatment
Doggui, S., Dao, L. H., & Ramassamy, C. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.84 · Cited by 18
Engineered nanoparticles for the treatment of Alzheimer’s disease
Jia, J., Zhao, S., Zhao, J., & Gao, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1510798 · Cited by 24
Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer’s disease
Mojarad-Jabali, S., & Roh, K. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125055 · Cited by 17
Intranasal Nanoparticulate Delivery Systems for Neurodegenerative Disorders: a Review
Babu, S. R., Shekara, H. H., Sahoo, A. K., Vardhan, P. V. H., Thiruppathi, N., & Venkatesh, M. P. (2023) · Therapeutic Delivery · doi:10.4155/tde-2023-0019 · Cited by 19
The behavioral performance tests of Mucuna pruriens gold nanoparticles in the 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine treated mouse model of Parkinsonism
Arulkumar, S., & Sabesan, M. (2012) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(12)60210-2 · Cited by 17
Polymeric nanoparticles: A promising strategy for treatment of Alzheimer's disease
Elmahboub, Y., & Elkordy, A. (2024) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2024.04.004 · Cited by 15
Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeutics
Mullis, A. S., Schlichtmann, B. W., Narasimhan, B., Cademartiri, R., & Mallapragada, S. K. (2018) · Biomedical Materials · doi:10.1088/1748-605x/aaa778 · Cited by 15
Polyglycerol‐Based Copper Chelators for the Transport and Release of Copper Ions in Biological Environments
Albrecht, R., Fehse, S., Pant, K., Nowag, S., Stephan, H., Haag, R., & Tzschucke, C. C. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500284 · Cited by 14
Synthesis and Characterization of Acylated Polycaprolactone (PCL) Nanospheres and Investigation of Their Influence on Aggregation of Amyloid Proteins
Ansari, M., Kordestani, S. S., Habibi-Rezaei, M., & Moosavi‐Movahedi, A. A. (2014) · Journal of Macromolecular Science Part B · doi:10.1080/00222348.2014.984578 · Cited by 14
Cellular uptake ofNigella sativaoil-PLGA microparticle by PC-12 cell line
Doolaanea, A. A., Mansor, N. I., Nor, N. H. M., & Mohamed, F. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2014.898709 · Cited by 15
Current advances in the utilization of nanotechnology for the diagnosis and treatment of diabetes
Devadasu, V. R., Alshammari, T. M., & Aljofan, M. (2017) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-017-0558-1 · Cited by 16
Intranasal Delivery to the Central Nervous System
Illum, L. (2015) · doi:10.1002/9781118788523.ch25 · Cited by 14
Alzheimer hastalığı tedavisinde nano boyutlu ilaç taşıyıcı sistemlerin kullanımı
GÜN, D. N. (2016) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000579 · Cited by 14
Kosmotropic and chaotropic effect of biocompatible Fe3O4 nanoparticles on egg white lysozyme; the key role of nanoparticle-protein corona formation
Akhtar, H., Pourmadadi, M., Yazdian, F. A., & Rashedi, H. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.132016 · Cited by 14
Lipopolysaccharide induced neuroprotective effects of bacterial protease against Alzheimer's disease in male Wistar albino rats
Azzam, S. M., Rahman, A. A. S. A., Ahmed-Farid, O. A.-H., El-Wafa, W. M. A., & Salem, G. E. M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123260 · Cited by 12
Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders
Govender, T., Choonara, Y. E., Kumar, P., Bijukumar, D. R., du Toit, L. C., Modi, G., Naidoo, D., & Pillay, V. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1189937 · Cited by 11
Flurbiprofen-loaded Nanoparticles Can Cross a Primary Porcine In vitro Blood-brain Barrier Model to Reduce Amyloid-β42 Burden
Stäb, J., & Zlatev, I. (2016) · Journal of Nanomedicine & Biotherapeutic Discovery · doi:10.4172/2155-983x.1000140 · Cited by 9
Inhibitors of transcription factor nuclear factor-kappa beta (NF-κβ)-DNA binding
Sharma, R. K., Otsuka, M., Gaba, G., & Mehta, S. (2012) · RSC Advances · doi:10.1039/c2ra21852f · Cited by 11
Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease
Antimisiaris, S. G., Mourtas, S., Markoutsa, E., Σκούρας, Α., & Παπαδιά, Κ. (2014) · Advanced Healthcare Materials · doi:10.1002/9781118774205.ch4 · Cited by 11
Schiff-Base Cross-Linked Poly(2-oxazoline) Micelle Drug Conjugates Possess Antiferroptosis Activity in Numerous In Vitro Cell Models
Morrow, J. P., Mazrad, Z. A. I., Warne, N. M., Ayton, S., Bush, A. I., & Kempe, K. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.3c01106 · Cited by 10
Photo-triggered Drug Delivery Systems for Neuron-related Applications
Li, W., Lin, J., Wang, T., & Huang, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180622121801 · Cited by 10
Nanogels: Update on the methods of synthesis and applications for cardiovascular and neurological complications
Ullah, A., & Lim, S. I. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103879 · Cited by 10
Molecular dynamics approach for behavior assessment of chitosan nanoparticles in carrying of donepezil and rivastigmine drug molecules
Mousavi, S. V., & Hashemianzadeh, S. M. (2019) · Materials Research Express · doi:10.1088/2053-1591/aafec6 · Cited by 10
Zinc oxide nanoparticle interface moderation with tyrosine and tryptophan reverses the pro-amyloidogenic property of the particle
Yadav, K. K., Ojha, M., Pariary, R., Arakha, M., Bhunia, A., & Jha, S. (2021) · Biochimie · doi:10.1016/j.biochi.2021.10.011 · Cited by 9
Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier
Fritzen, L., Wienken, K., Wagner, L., Kurtyka, M., Vogel, K., Körbelin, J., Weggen, S., Fricker, G., & Pietrzik, C. U. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00573-1 · Cited by 10
Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disorders
Zhu, T.-T., Liu, P., Hashimoto, K., & Yang, J. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03603-6 · Cited by 10
Nanomedicine: A New Frontier in Alzheimer’s Disease Drug Targeting
Pathak, K., Ahmad, M. Z., Saikia, R., Pathak, M. P., Sahariah, J. J., Kalita, P., Das, A., Islam, M. A., Pramanik, P., Tayeng, D., et al. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249281331240325042642 · Cited by 11
Effect of Magnesium Oxide Nanoparticles on Atropine-Induced Memory Impairment in Adult Male Mice
nootarki, Z. S., Kesmati, M., & Borujeni, M. P. (2015) · Avicenna Journal of Neuro Psych Physiology · doi:10.17795/ajnpp-36924 · Cited by 9
QUANTIFICATION OF NIGELLA SATIVA OIL (NSO) FROM BIODEGRADABLE PLGA NANOPARTICLES USING FTIR SPECTROSCOPY
Doolaanea, A. A., Harun, A. F., & Mohamed, F. (2014) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 8
Intranasal delivery route for neurodegenerative diseases: recent insights and future directions
Correale, J. D., Mattera, V. S., & Pasquini, J. M. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01919-4 · Cited by 10
Newly Designed Magnetic and Non-Magnetic Nanoparticles for Potential Diagnostics and Therapy of Alzheimer?s Disease
Skaat, H. (2013) · Journal of Biotechnology & Biomaterials · doi:10.4172/2155-952x.1000156 · Cited by 8
Poly (n-butyl cyanoacrylate) as a nanocarrier for rivastigmine transport across the blood–brain barrier in Alzheimer’s disease treatment: a perspective from molecular dynamics simulations
Mousavi, S. V., & Hashemianzadeh, S. M. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3799-0 · Cited by 8
MYCOBIOSYNTHESIS OF METAL NANOPARTICLES
Das, K., & Thiagarajan, P. (2012) · Cited by 8
Application of Nanotechnology in Diagnosis and Therapeutics
Kumari, R. M., Goswami, R., & Nimesh, S. (2020) · Green energy and technology · doi:10.1007/978-3-030-33774-2_18 · Cited by 8
Nanotechnology-Mediated Nose-to-Brain Drug Delivery for Neurodegenerative Disorders
Pardeshi, C. V., Belgamwar, V. S., & Surana, S. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_6 · Cited by 7
From the nose to the brain, nanomedicine drug delivery
Zeeshan, F., Mishra, D. K., & Kesharwani, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820466-5.00008-9 · Cited by 7
Phytoconstituents-based nanoformulations for neurodegenerative disorders
Rajput, M. S., Nirmal, N. P., Patel, V. A., Sarkar, P. D., & Raval, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19143-5.00003-7 · Cited by 6
Targeting Amyloids with Coated Nanoparticles: A Review on Potential Combinations of Nanoparticles and Bio-Compatible Coatings
Warerkar, O. D., Mudliar, N. H., Momin, M. M., & Singh, P. K. (2023) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2023046209 · Cited by 7
Magnetic Nanoparticles as Delivery Systems to Penetrate the Blood-Brain Barrier
Estelrich, J., & Busquets, M. A. (2020) · Neuromethods · doi:10.1007/978-1-0716-0838-8_7 · Cited by 6
Nanomedicine breakthroughs in cancer and neurodegenerative disease therapy
Haque, A., Khan, T., Islam, R. U., & Naseem, S. (2025) · Next Nanotechnology · doi:10.1016/j.nxnano.2025.100233 · Cited by 5
Bioactive poly(2-oxazoline)-based nanomaterials bearing arylalkylamine and benzamide motifs possess intrinsic radical trapping and anti-ferroptosis properties
Morrow, J. P., Pizzi, D., Mazrad, Z. A. I., Bush, A. I., & Kempe, K. (2023) · Biomaterials Science · doi:10.1039/d2bm02087d · Cited by 5
RETRACTED: Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy
Zhao, F., Yang, H., Gao, Z., Liu, H., Wu, P., Li, B., Yu, H., & Shao, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23563 · Cited by 5
Retracted
Global Current Trends in Drug Designing for Management of Type-2 Diabetes and Neurodegenerative Disorders
MZ, A. Q. A. (2013) · Drug Designing Open Access · doi:10.4172/2169-0138.1000e120 · Cited by 5
Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer’s Disease
Dogra, A., Narang, R. S., & Narang, J. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200422092620 · Cited by 5
Novel Biomaterials Based Strategies for Neurodegeneration: Recent Advancements and Future Prospects
Singh, D., & Nagdev, S. A. (2024) · Current Drug Delivery · doi:10.2174/0115672018275382231215063052 · Cited by 4
Bio-nano Interface and Its Potential Application in Alzheimer’s Disease
Pradhan, B., Jit, B. P., Maharana, S., Ramchandani, S., & Jena, M. (2021) · Springer eBooks · doi:10.1007/978-981-16-2516-9_12 · Cited by 5
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.
Wang, W. T., Tailor, B. A., Cohen, D. S., & Huang, X. (2019) · PubMed · Cited by 4
Solid lipid nanoparticle a complete tool for brain targeted drug delivery
Ramalingam, P., Dutta, G., Mothilal, M., & Sugumaran, A. (2025) · Current Issues in Pharmacy and Medical Sciences · doi:10.12923/cipms-2025-0002 · Cited by 3
Computer-Aided Multi-Target Management of Emergent Alzheimer’s Disease
Kim, H., & Han, H. W. (2018) · Bioinformation · doi:10.6026/97320630014167 · Cited by 3
Cell Microencapsulation Implants into the Central Nervous System
Spuch, C., & Navarro, C. (2011) · Current Nanomedicine · doi:10.2174/1877912311101010060 · Cited by 3
CNS Drug Delivery for Diseases Eradication: An Overview
Kalvala, A. K., Giri, P., Kaligatla, J., Khan, W., & Kumar, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-63633-7_10 · Cited by 3
OPTIMIZATION AND CHARACTERIZATION OF RIVASTIGMINE-LOADED NANOSTRUCTURED LIPID CARRIERS
Ganna, S., Kotakadi, S. M., Mohammed, R. A., Shaik, M. I., & Nannepaga, J. S. (2021) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2021v13i3.42093 · Cited by 3
Natural Products Targeting Alzheimer’s Disease via NF-κB Pathway: A Review
Hasan, F., Thippamma, K., Kumar, V., Baiseitova, A., Ikram, M. A., & Shah, A. B. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273397045250922054643 · Cited by 2
Nano Encapsulation for the Targeted Drug Delivery to Enhance the Efficacy of Drugs
Kumar, V., & Dutta, R. (2025) · Algorithms for intelligent systems · doi:10.1007/978-981-96-3648-8_9 · Cited by 2
The Therapeutic Potential of Cell Encapsulation Technology for Drug Delivery in Neurological Disorders
Spuch, C., & Navarro, C. (2011) · InTech eBooks · doi:10.5772/23222 · Cited by 2
The Strategies of Nanomaterials for Therapy
Du, Y., Wang, S., Li, F., & Ling, D. (2019) · Springer eBooks · doi:10.1007/978-981-13-8731-9_4 · Cited by 2
Fractional CO2 laser versus Microneedling followed by Topical 5 Fluorouracil in the treatment of Non-Segmental Vitiligo
El-Aal, E. B. A., Fahmy, S., & Kandil, H. A. H. (2024) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.58675/2682-339x.2376 · Cited by 1
A Review on Nanotechnology in Diagnosis and Treatment of Alzheimer’s Disease
Venkateswara Rao., S., Sravya, K., & Padmalatha, K. (2018) · American Journal of PharmTech Research · doi:10.46624/ajptr.2018.v8.i6.001 · Cited by 1
O-Phenylenediamine Encapsulated Silver Nanoparticles and Their Applications for Organic Light-Emitting Devices
Ha, C., Park, J., & Ullah, H. (2010) · InTech eBooks · doi:10.5772/8503 · Cited by 1
A Comprehensive Review on Disease Related Applications of Nanotechnology
Pavithra, S., & Senthilnathan, B. (2023) · EAS Journal of Pharmacy and Pharmacology · doi:10.36349/easjpp.2023.v05i04.003 · Cited by 1
透過金屬離子結合、家族性突變型、以及奈米金粒子瞭解阿茲海默症乙型類澱粉蛋白纖維化的複雜性
廖宜鴻 (2014) · doi:10.6342/ntu.2014.00879
Physicochemical Properties for Potential Alzheimer’s Disease Drugs
Ates-Alagoz, Z., & Adejare, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00005-2
Improved anti-amnesic activity of tacrine loaded pla polymeric nanoparticles
Joe, F., & S, S. K. (2017) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2017.8.2.p117-129
Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease
Talegaonkar, S., Gautam, N., Varshney, V., Sharma, S., & Bhattacharyya, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_13
Direct Visualization of Single Molecule Amyloid Beta Peptides in Action by High-Speed Atomic Force Microscopy
Feng, L. (2019) · Research Online (University of Wollongong)
Wine and Vine Components and Health
Latruffe, N., & Rifler, J.-P. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-139-5
Curcumin loaded drug delivery systems in Parkinson’s disease
Obulesu, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822448-9.00007-8
Applications of nose-to-brain delivery in nanodiagnosis and nanotherapy of neurodegenerative disorders
Kulkarni, A. D., Shinde, M. N., Sonawane, G. A., Raotole, H., Pande, R., & Pardeshi, C. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00016-3
Polyphenols in neuroprotection and brain disorders
Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00004-9

Authors: Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C.
Affiliations: Institut National de la Recherche Scientifique (CA)
Jamia Hamdard (IN)
Corresponding author: Ramassamy, Charles
ORCID: Ali, Javed
Baboota, Sanjula
Ramassamy, Charles
Venue: Journal of Controlled Release
Publisher: Elsevier BV
Published: 2011-06
Volume: 152
Issue: 2
Pages: 208-231
ISSN: 0168-3659 (ISSN-L)
DOI: 10.1016/j.jconrel.2010.11.033
OpenAlex: W2040364087
Cited by: 219
References: 352
Citations by year: 2026: 4 · 2025: 10 · 2024: 11 · 2023: 14 · 2022: 17 · 2021: 14 · 2020: 16 · 2019: 21 · 2018: 18 · 2017: 14 · 2016: 17 · 2015: 16 · 2014: 13 · 2013: 15 · 2012: 13
FWCI: 0.54
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Controlled Release (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
EspaceINRS (National Institute for Scientific Research (Canada)) (submittedVersion)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords: Alzheimer's disease, nanoparticles, nanocarriers, blood-brain barrier, targeted drug delivery, brain drug delivery, drug encapsulation, nanomedicine, route of administration, neurodegenerative diseases
MeSH terms: Alzheimer Disease, Amyloid, Animals, Blood-Brain Barrier, Chelating Agents, Cholinesterase Inhibitors, Flavonoids, Hormones, Humans, Phenols, Vasoactive Intestinal Peptide, Drug Delivery Systems, Nanoparticles, Polyphenols

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurotherapeutic applications of nanoparticles in Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks